AR013960A1 - Nuevos compuestos y metodos para sintesis y terapia - Google Patents

Nuevos compuestos y metodos para sintesis y terapia

Info

Publication number
AR013960A1
AR013960A1 ARP980104638A ARP980104638A AR013960A1 AR 013960 A1 AR013960 A1 AR 013960A1 AR P980104638 A ARP980104638 A AR P980104638A AR P980104638 A ARP980104638 A AR P980104638A AR 013960 A1 AR013960 A1 AR 013960A1
Authority
AR
Argentina
Prior art keywords
methods
neuraminidase
group
new compounds
therapy
Prior art date
Application number
ARP980104638A
Other languages
English (en)
Spanish (es)
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR013960A1 publication Critical patent/AR013960A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP980104638A 1997-09-17 1998-09-17 Nuevos compuestos y metodos para sintesis y terapia AR013960A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5930897P 1997-09-17 1997-09-17
US93864497A 1997-09-26 1997-09-26
US6019597P 1997-09-26 1997-09-26

Publications (1)

Publication Number Publication Date
AR013960A1 true AR013960A1 (es) 2001-01-31

Family

ID=27369627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104638A AR013960A1 (es) 1997-09-17 1998-09-17 Nuevos compuestos y metodos para sintesis y terapia

Country Status (15)

Country Link
EP (1) EP1015417A1 (cs)
JP (1) JP2001516739A (cs)
KR (1) KR20010024123A (cs)
CN (1) CN1272105A (cs)
AR (1) AR013960A1 (cs)
AU (1) AU747702B2 (cs)
BR (1) BR9812649A (cs)
CA (1) CA2303323A1 (cs)
EA (1) EA003989B1 (cs)
ID (1) ID25516A (cs)
IL (1) IL134691A0 (cs)
IN (1) IN190983B (cs)
NZ (1) NZ502988A (cs)
TR (1) TR200000723T2 (cs)
WO (1) WO1999014185A1 (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1040094B9 (en) * 1997-12-17 2015-09-09 Biocryst Pharmaceuticals Inc. Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
ATE241589T1 (de) * 1999-06-11 2003-06-15 Hoffmann La Roche Verfahren zur herstellung des neuraminidase- inhibitoren ro-64-0796
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
BR0010525A (pt) * 1999-10-19 2002-11-26 Abbott Lab cido 1-ciclo-hexeno-1-carboxìlico e 1-ciclo-hexeno-1carboxilatos como inibidores de neuraminidase
JP2001131144A (ja) 1999-11-02 2001-05-15 Sagami Chem Res Center 7−アザビシクロ[4.1.0]ヘプト−3−エン−3−カルボン酸エステル類の製造方法
US6403824B2 (en) * 2000-02-22 2002-06-11 Hoffmann-La Roche Inc. Process for the preparation for 4,5-diamino shikimic acid derivatives
WO2001080892A1 (fr) * 2000-04-25 2001-11-01 Sankyo Company, Limited Substances preventives de la grippe
WO2002092555A1 (fr) * 2001-05-11 2002-11-21 Sankyo Company, Limited Derives d'acides sialiques
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
EP2178819A2 (en) * 2005-12-28 2010-04-28 F.Hoffmann-La Roche Ag Epoxide intermediate in the tamiflu synthesis
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
JP5837502B2 (ja) * 2009-11-11 2015-12-24 スリーエム イノベイティブ プロパティズ カンパニー ポリマー組成物並びにその製造方法及び物品
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
CN102659615B (zh) * 2012-05-09 2014-05-07 中国药科大学 奥司他韦衍生物、其制备方法及其医药用途
RU2520836C1 (ru) * 2013-02-27 2014-06-27 Александр Васильевич Иващенко (3r,4r,5s)-4-амино-5-(2,2-дифторацетиламино)-3-(1-этилпропокси)-циклогекс-1-енкарбоновая кислота и ее эфиры, способ их получения и применения
RU2633085C2 (ru) * 2014-05-20 2017-10-11 Российская Федерация, от имени которой выступает Федеральное государственное казенное учреждение "Войсковая часть 68240" Противовирусное лекарственное средство в виде капсул и способ его получения
CN105439884A (zh) * 2015-10-27 2016-03-30 沈阳药科大学 一种奥司他韦的制备方法
CN108047076B (zh) * 2017-12-26 2020-05-08 杭州新博思生物医药有限公司 一种奥司他韦对映异构体的制备方法
CN110194728B (zh) * 2019-06-19 2021-04-30 湖南华腾制药有限公司 磷酸奥司他韦中间体的连续化合成方法
WO2022022448A1 (zh) * 2020-07-29 2022-02-03 广州市恒诺康医药科技有限公司 神经氨酸酶抑制剂类化合物、其药物组合物及其用途
CN116375595A (zh) * 2023-03-31 2023-07-04 重庆医药高等专科学校 一种磷酸奥司他韦的制备方法及精制方法
CN117105801A (zh) * 2023-07-24 2023-11-24 四川青木制药有限公司 一种奥司他韦及其磷酸盐的制备方法及其中间体
CN116666669B (zh) * 2023-07-25 2023-10-03 四川大学 VN负载的Ir团簇及其制备方法与其在催化剂中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
KR100447096B1 (ko) * 1995-02-27 2005-10-11 갈리드사이언스인코오퍼레이티드 바이러스성또는세균성뉴라미니다제의신규한선택적저해제
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
WO1998007685A1 (en) * 1996-08-23 1998-02-26 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives

Also Published As

Publication number Publication date
AU747702B2 (en) 2002-05-16
NZ502988A (en) 2002-08-28
EA200000332A1 (ru) 2000-10-30
EP1015417A1 (en) 2000-07-05
KR20010024123A (ko) 2001-03-26
IN190983B (cs) 2003-09-06
ID25516A (id) 2000-10-05
TR200000723T2 (tr) 2001-06-21
WO1999014185A1 (en) 1999-03-25
AU9569498A (en) 1999-04-05
CA2303323A1 (en) 1999-03-25
EA003989B1 (ru) 2003-12-25
IL134691A0 (en) 2001-04-30
BR9812649A (pt) 2000-08-22
CN1272105A (zh) 2000-11-01
JP2001516739A (ja) 2001-10-02

Similar Documents

Publication Publication Date Title
AR013960A1 (es) Nuevos compuestos y metodos para sintesis y terapia
ES2118674T3 (es) Nuevos inhibidores selectivos de neuraminidasas virales o bactericidas.
CY2018023I2 (el) Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης
AR019507A1 (es) Uso de los inhibidores de cyp2d6 en terapias de combinacion
CY1106992T1 (el) Καχαλαλιδη f και συναφεις ενωσεις
PT1105122E (pt) Composicoes farmaceuticas que contem inibidores de lipase
ES2184408T3 (es) Sistema transdermico que contiene un antioxidante.
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
ES2136415T3 (es) Procedimiento para la fabricacion de poliesteres utilizando combinaciones de catalizador que contiene titanio e inhibidor.
PT884994E (pt) Utilizacoes de adesivo para protese dentaria que contem extracto de aloe
IT1291623B1 (it) Procedimento per la coniugazione di chelanti con molecole contenenti gruppi amminici
BR9808758A (pt) Derivados de cisteìna, processo para sua produção e farmacêuticos contendo os mesmos
ES2179529T3 (es) Compuestos biaromaticos unidos por un radical heteroetinileno, y composiciones farmaceuticas y cosmeticas que los contienen.
ES2285735T3 (es) Modelo molecular para inhibidores de vla-4.
HN1999000101A (es) Inhibidores de las fkbp.
EA200000112A1 (ru) Новая композиция
EP0976734A3 (en) Selective inhibitors of viral or bacterial neuraminidase
DK0952982T3 (da) Hidtil ukendte hepatitis B inhibitorer
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
UA1765S (uk) Комплект етикеток для пляшки
UA1769S (uk) Комплект етикеток для пляшки
UA1768S (uk) Комплект етикеток для пляшки
UA1770S (uk) Комплект етикеток для пляшки
BR9703847A (pt) Escala para medir tempo de reação
LV11875A (lv) Iekarta starojuma avota attaluma un peilejuma noteiksanai

Legal Events

Date Code Title Description
FB Suspension of granting procedure